•  •  Dark Mode

Your Interests & Preferences

I am a...

law firm lawyer
in-house company lawyer
litigation lawyer
law student
aspiring student

Website Look & Feel

 •  •  Dark Mode
Blog Layout

Save preferences

D&D, Platinum, SAM, KCo advised on $350m ChrysCap, GIC investment in Mankind Pharma

India-bred private equity firm Chrys Capital is set to buy 10 per cent in fast-growing Mankind Pharmaceuticals for $350 million. GIC of Singapore and CPPIB of Canada may co-invest in the deal, likely to be signed this week.

Business Standard

Desai & Diwanji advised GIC, the sovereign wealth fund of the Government of Singapore led by a team of partner Shreevardhan Sinha and associate Shreya Iyer.

Update 29 May 2019: Platinum Partners advised Capital International led by a team of partner Ankit Majmudar.

Shardul Amarchand Mangaldas and Khaitan & Co also advised.


Deal value: Approx USD 350 mn

This deal report is based on a firm's press release and may be only partially complete. Some firms or names of advisers may be therefore be missing.

No comments yet: share your views